Tardive Dyskinesia
Long-term risperidone improves symptoms of pre-existing severe TD
Published in Mental Health Weekly Digest, March 14th, 2005
"Atypical antipsychotics can alleviate the severity of tardive dyskinesia, but few studies have monitored their long-term effects. The present study investigated the effect of risperidone on pre-existing severe tardive dyskinesia among 40 patients with chronic schizophrenia over 48 weeks," wrote Ya-Mei Bai, National Yang-Ming University, Taipei, and colleagues.
They reported, "The total Abnormal Involuntary Movement Scale (AIMS) score decreased in 35 patients (87.5%) and increased in three patients (7.5%).
"At the end...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest
More Articles from Mental Health Weekly Digest
- Bipolar Disorder
Treatment guidelines for children published - Depression
Study validates three instruments for assessing depressive symptoms - Depression
Suicidal behavior caused by antidepressants "cannot be ruled out" - Stress
Researchers issue wake-up call over teen mental health - Alzheimer Disease
Phase 2 clinical study for Alzheimer disease completed - Amyloid Peptides
Amyloid peptides studied, role on cell differentiation and viability shown - More from this issue of Mental Health Weekly Digest
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
